Status:
COMPLETED
Text Messaging to Reduce Alcohol Relapse in Liver Transplant Patients
Lead Sponsor:
Yale University
Conditions:
Alcoholic Liver Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a research study of a text-messaging intervention to reduce alcohol relapse risk in pre-transplant liver transplantation patients. This study is an 8-week, randomized controlled pilot trial to...
Detailed Description
This study is an 8-week, randomized controlled pilot trial to investigate the feasibility and acceptability of a text-messaging intervention for alcohol relapse prevention and stress reduction in 20 l...
Eligibility Criteria
Inclusion
- at least 18 years of age;
- diagnosis of alcohol-related liver disease;
- currently in evaluation for UNOS listing as a liver transplant candidate;
- last reported use of any alcohol within the past 1 year;
- willingness to receive and respond to multiple text messages per day.
Exclusion
- unstable psychiatric/medical conditions such as suicidal ideation, acute psychosis, or dementia.
Key Trial Info
Start Date :
March 22 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 6 2014
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT03402256
Start Date
March 22 2013
End Date
May 6 2014
Last Update
January 18 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale Transplantation Center/Yale-New Haven Hospital
New Haven, Connecticut, United States, 06510